Evidence for Validity of a National Physician and Patient-Reported Survey in China and United Kingdom: The Disease Specific Programme
Value Health
.
2014 Nov;17(7):A728.
doi: 10.1016/j.jval.2014.08.065.
Epub 2014 Oct 26.
Authors
S M Babineaux
1
,
B H Curtis
1
,
T Holbrook
2
,
L Liu
3
,
H Colclough
4
,
J Piercy
4
Affiliations
1
Eli Lilly & Company, Indianapolis, IN, USA.
2
Adelphi Real World, Bollington, UK.
3
Eli Lilly Suzhou Pharmaceutical Co. Ltd., Shanghai, China.
4
Adelphi Real World, Cheshire, UK.
PMID:
27202594
DOI:
10.1016/j.jval.2014.08.065
No abstract available